Juniper Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 4.95 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.73 Cr
- Revenue Growth 59.81%
- Profit Growth -39.07%
- Ebitda 62.23%
- Net Worth 59.66%
- Total Assets 76.44%
About Juniper Life Sciences
Juniper Life Sciences Private Limited (JLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 2021 (Three years and nine months 23 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.95 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.73 Cr.
Vincent Mathew and Nimmy Philip serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909KA2021PTC146702
-
Company No.
146702
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Juniper Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vincent Mathew
|
Director | 19-Apr-2021 | Current |
|
Nimmy Philip
|
Director | 19-Apr-2021 | Current |
Financial Performance of Juniper Life Sciences.
Juniper Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.81% increase. The company also saw a substantial fall in profitability, with a 39.07% decrease in profit. The company's net worth Soared by an impressive increase of 59.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Juniper Life Sciences?
Unlock access to Juniper Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Silicon Scientific Private LimitedVincent Mathew is a mutual person
Charges (Loans)
₹57.30 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.55 Cr
- Canara Bank : 2.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2024 | Others | ₹1.15 Cr | Open |
| 21 Jan 2023 | Others | ₹2.40 Cr | Open |
| 18 Aug 2022 | Canara Bank | ₹2.18 Cr | Open |
How Many Employees Work at Juniper Life Sciences?
Juniper Life Sciences has a workforce of 16 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Juniper Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Juniper Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.